Equities

Anteotech Ltd

Anteotech Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.022
  • Today's Change-0.001 / -4.35%
  • Shares traded485.74k
  • 1 Year change-55.10%
  • Beta1.5946
Data delayed at least 20 minutes, as of Jun 07 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.

  • Revenue in AUD (TTM)526.75k
  • Net income in AUD-11.46m
  • Incorporated1995
  • Employees40.00
  • Location
    Anteotech LtdBrisbane Technology ParkSE 4 26 Brandl StEIGHT MILE PLAINS 4113AustraliaAUS
  • Phone+61 73219-0085
  • Fax+61 73219-0553
  • Websitehttps://www.anteotech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Invion Ltd4.46m-1.50m32.12m8.00--1.80--7.20-0.0002-0.00020.00070.00280.2345--3.20---7.88-16.93-8.12-18.13-----33.60-51.63----0.00--25.7241.1827.95------
BCAL Diagnostics Ltd3.67m-5.00m35.32m----5.81--9.61-0.0227-0.02270.01660.02410.4493--3.21---61.10-54.01-67.83-62.57-----136.00-248.64---131.830.1985--298.6363.18-49.51--91.62--
Little Green Pharma Ltd23.24m-3.14m36.21m----0.446354.191.56-0.011-0.01260.08330.26890.2631.1312.06---3.55---4.01--51.02---13.51--2.03-21.270.0667--------------
IDT Australia Limited10.36m-6.55m36.91m156.00--1.60--3.56-0.022-0.0220.0350.06560.37412.393.51---23.64-9.87-26.41-11.5776.3884.42-63.19-24.942.81--0.0907---42.03-11.97-632.59---26.04--
Prescient Therapeutics Ltd697.94k-7.74m37.85m3.00--1.67--54.23-0.0098-0.00980.00090.02810.0276--2.32---30.58-27.61-32.59-29.03-----1,109.58-3,284.78---412.910.00--939.1629.68-36.88------
Starpharma Holdings Ltd10.63m-8.40m41.20m50.00--1.20--3.88-0.0205-0.02050.02590.08370.20920.2822.10---16.53-28.47-20.70-33.6692.6771.62-79.00-391.825.22--0.0833---14.10-3.223.19--11.58--
LTR Pharma Ltd-100.00bn-100.00bn45.06m----14.20----------0.0451----------------------------0.00---100.00---41.65------
Biotron Ltd1.65m-4.02m49.63m4.00--26.55--30.17-0.0045-0.00450.00180.00210.3587-------87.73-64.30-103.46-74.43-156.30-108.03-244.54-231.62----0.0148---8.16-2.48-25.59------
Inoviq Ltd751.54k-6.51m51.07m85.00--3.05--67.95-0.0708-0.07080.00820.1820.03392.100.873---29.33-47.68-32.18-50.7695.07---866.27-2,527.824.93--0.0332--119.59153.3150.71------
Anteotech Ltd526.75k-11.46m54.21m40.00--10.17--102.92-0.0056-0.00560.00030.00220.0552--2.62---120.11-68.55-145.22-75.44-----2,176.15-1,432.10----0.1729---46.6511.41-18.08--25.84--
Vitura Health Ltd119.67m9.40m54.71m121.005.771.3914.470.45720.01650.01650.20990.06811.9811.2210.51989,034.2015.2515.2922.3021.0631.23--7.706.921.185,598.190.2359--75.16--128.31146.9554.86--
Cynata Therapeutics Ltd436.25k-13.65m55.69m0.00--4.54--127.65-0.0873-0.08730.00270.06830.0257--4.26---80.33-38.07-87.15-41.10-----3,127.93-513.73----0.00---94.9619.81-162.20------
Neurotech International Ltd1.28m-4.98m57.99m----10.60--45.40-0.0058-0.00580.00150.00540.1826-0.11495.67---71.23-197.33-74.66-255.24100.0779.57-390.03-1,043.8818.35--0.00--106.2283.24-131.75------
Biome Australia Ltd10.24m-2.86m68.10m30.00--31.59--6.65-0.0141-0.01410.05060.01011.371.936.04341,434.70-38.27---74.60--61.29---27.97--0.9514-15.920.4032--73.58--32.20------
Orthocell Ltd6.06m-7.42m73.26m----32.02--12.10-0.0369-0.03690.03010.01090.21821.5027.68---26.73-32.67-31.96-38.5377.1163.04-122.55-374.464.36--0.2586--215.2451.5331.39--11.07--
Data as of Jun 07 2024. Currency figures normalised to Anteotech Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.